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Cover Image: Phase contrast vastly under-sampled isotropic projection reconstruction imaging (PC-VIPR) is a novel
magnetic resonance imaging technique developed at the University of Wisconsin–Madison. By providing noninvasive
imaging with flow quantification, it holds promise for identifying malperfusion in patients suffering from aortic dissection.
The cover photo is a “4D” phase contrast velocity image produced with PC-VIPR and depicts differential flow velocities in
the true and false lumen of a 51-year-old man after operative repair of the ascending aorta for acute aortic dissection. The
color scale (yellow, 50 cm/s; red, 25 cm/s) of the rendered streamlines reveals differences in velocities in the two lumens and
complex helical flow within the ascending aortic graft. Courtesy of Benjamin R. Landgraf, BS, Mark L Schiebler, MD,
Christopher J Francois, MD, Scott B Reeder, MD, PhD, Oliver Wieben, PhD, and Kevin Johnson, PhD.
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